Mouse HMGB-1(Highmobility group protein B1) ELISA Kit
中文名称：小鼠高迁移率族蛋白B1(HMGB-1)酶联免疫吸附测定试剂盒
Price:
- 反应性： Mouse
- 检测范围： 15.63-1000 pg/mL
- 灵敏度： 9.38 pg/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠HMGB-1抗体包被于酶标板上，实验时样品（或标准品）中的小鼠HMGB-1会与包被抗体结合。后依次加入生物素化的抗小鼠HMGB-1抗体和辣根过氧化物酶标记的亲和素，抗小鼠HMGB-1抗体与结合在包被抗体上的小鼠HMGB-1结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，HMGB-1浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中HMGB-1的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Mouse |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 15.63-1000 pg/mL |
| 灵敏度 | 9.38 pg/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的小鼠HMGB-1，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
Eradication of Large Tumors by Nanoscale Drug Self-Assembly
IF: 27.400 -
Thermal-triggered mitochondrial oxidative phosphorylation-enhanced nanodrug sensitizes cuproptosis with amplified anti-tumor immunity
IF: 21.100 -
M2 Macrophage-Derived Exosomes Inhibiting Neutrophil Extracellular Traps for Ischemic Stroke Therapy
IF: 18.500Journal： ADVANCED FUNCTIONAL MATERIALS (2024)Reactivity：MouseSample Type：plasma -
Controlling Alveolar Bone Loss by Hydrogel-Based Mitigation of Oral Dysbiosis and Bacteria-Triggered Proinflammatory Immune Response
IF: 18.500Journal： ADVANCED FUNCTIONAL MATERIALS (2024) -
NIR-II photo-accelerated polymer nanoparticles boost tumor immunotherapy via PD-L1 silencing and immunogenic cell death
IF: 18.000 -
A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer
IF: 14.700 -
Rational design of ICD-inducing nanoparticles for cancer immunotherapy
IF: 13.600 -
A smart-responsive Y-shaped DNA scaffold drug conjugate achieving precise and synergetic tumor chemo-gene therapy via promoting tumor apoptosis and activating the anti-tumor immunity
IF: 13.300 -
Tea leaf-derived nanovesicles for ferric-supply-amplified ICD and macrophage reprogramming to boost immunotherapy against head and neck squamous carcinoma
IF: 13.300 -
Intrinsic tumor-targeted murine Ferritin nanocage co-delivers GPX4 and FSP1 inhibitors for synergistic ferroptosis-immunotherapy
IF: 13.200Journal： Nano Today (2024)Reactivity：MouseSample Type：CT26 cell-Xenograft
实验操作视频
